Allarity Therapeutics Files 8-K

Ticker: ALLR · Form: 8-K · Filed: Jul 16, 2025 · CIK: 1860657

Sentiment: neutral

Topics: 8-k, sec-filing, corporate-update

Related Tickers: ALLR

TL;DR

Allarity Therapeutics (ALLR) filed an 8-K on 7/15/25. Standard update.

AI Summary

Allarity Therapeutics, Inc. filed an 8-K on July 15, 2025, reporting other events and financial statements. The company, incorporated in Delaware with its principal executive offices in Tarpon Springs, FL, is in the pharmaceutical preparations industry.

Why It Matters

This filing indicates that Allarity Therapeutics is providing updates on its corporate activities and financial status to the SEC.

Risk Assessment

Risk Level: low — This is a routine filing reporting corporate events and financial statements, not indicating any immediate material changes or risks.

Key Numbers

Key Players & Entities

FAQ

What is the primary purpose of this 8-K filing?

The filing is a Current Report pursuant to Section 13 or 15(d) of The Securities Exchange Act of 1934, reporting 'Other Events' and 'Financial Statements and Exhibits'.

When was this report filed and what is the earliest event date?

The filing was made on July 16, 2025, and the earliest event reported is dated July 15, 2025.

Where are Allarity Therapeutics, Inc.'s principal executive offices located?

The principal executive offices are located at 123 E Tarpon Ave, Tarpon Springs, FL 34689.

What is Allarity Therapeutics, Inc.'s Standard Industrial Classification code?

The company's SIC code is 2834, which corresponds to Pharmaceutical Preparations.

What is the company's state of incorporation?

Allarity Therapeutics, Inc. is incorporated in Delaware.

Filing Details

This Form 8-K (Form 8-K) was filed with the SEC on July 16, 2025 regarding Allarity Therapeutics, Inc. (ALLR).

View full filing on EDGAR

View Full Filing

View this 8-K filing on SEC EDGAR

View on Read The Filing